Everything I say is my own opinion. Do not interpret anything stated as investment advice. I am not a registered Financial Adviser of any kind.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
"Wrong, read the filing closer. The convertible aspect of the notes is not guaranteed, and they didn't issue the 1.6M up front. Hence, they are risking alot, for potentially nothing (or little) to gain.
1) The notes are only convertible if not repaid within 90 days
2) Issued in successive installments of approx 150k
So for them to make money with that strategy, if they started it now, they would have to
1) Suppress the price for 90 days (when they only get a rate based on 15 prior to expiration...)
2) Hope the company defaults on its payments
3) Hope the company doesn't finalize a JV, resulting in a massive short loss
All the while only getting a possible 150K worth of shares a bit cheaper for every 90 days of this?
C'mon now... Child's play.. No sophisticated lender would see the cost benefit favorable on that strat."
-Lord
Well sure, anything breaking a 50 day moving average in a bearish manner is going to see a bit of a dump.
However, you say these things without offering any support as to why they even 'may' happen.
Just pure speculation coming from you - and its always negative. I'm pointing it out so the less sophisticated chartists know what you are.
The bull thesis would be that it bounces on account of the recent, similar bounce, as well as the anticipated JV's. I just don't see any fundamental reasoning from you as to why it wouldn't.
-Lord
Hey Panda, what happened to BIEI going to the 0.01's?
You've been calling that for days on end now.
Enough with the blind negativity, how about you actually provide support for something for once.
This looks hella scammy... Someone please explain the investment thesis here. I see unsubstantiated conjecture based upon one man purchasing his own private company by a public shell corp. I could perform this transaction in 2 days myself; it fully lacks any economic substance.
Really though.. don't get defensive from this post. Just wanting to start dialogue, please explain why this is worthy of investment.
Good Luck to ALL
-Lord
Gentleman, you are welcome for that blow past three moments ago.
Position is now fully loaded. This thing is going over 0.05 easy.
Friend of mine finally convinced me to get in here; Science seems solid.
SBFM and BIEI are going to have a hell of a few months coming up.
Good Luck to ALL
-Lord
Shareholder base showing exceptional strength here...
Nobody is selling in the 0.02's; love to see it.
Strong hands know what they own.
Good things to come here on the next news release (or even a bit before).
Good Luck to ALL
-Lord
Fair enough, I'd be happy to just see it trade sideways here until news as well. Seems very tightly bound at these prices; nobody is selling.
Wrong, I think you need to read the filing closer. The convertible aspect of the notes is not guaranteed, and they didn't issue the 1.6M up front. Hence, they are risking alot, for potentially nothing (or little) to gain.
1) The notes are only convertible if not repaid within 90 days
2) Issued in successive installments of approx 150k
So for them to make money with that strategy, if they started it now, they would have to
1) Suppress the price for 90 days (when they only get a rate based on 15 prior to expiration...)
2) Hope the company defaults on its payments
3) Hope the company doesn't finalize a JV, resulting in a massive short loss
All the while only getting a possible 150K worth of shares a bit cheaper for every 90 days of this?
C'mon now... Child's play.. No sophisticated lender would see the cost benefit favorable on that strat.
-Lord
Na man... or at least not until 15 days before the expiration of the first note; so approximately 75 days from now. Until then, there is no reason to try to short or suppress this yet. The costs to hold it down for that long would be tremendous and the position would grow very large - which would indicate heavy exposure to losses should one of the companies JV's go through.
I think they're probably just alright with the 5% normal repayment schedule with the chance for cheapy shares and/or 130% of normal interest on prepayment before deadlines. Not to mention building a relationship for future transactions.
Just my honest opinion, but it takes a bit more work to press on a SP for that long than you think.
-Lord
Pretty sure you missed your chance today... at least on a technical level.
Might be another chance before JV announcements though.
Hahahaha seriously man? There is absolutely no technical or fundamental support for anything near that happening; especially after the shareholder strength that was displayed today. Little to no selling under 0.025
Egg-xactly.
A large golden egg-xactly.
Non-toxic is a chemical term... hence they could say that about any financing arrangement. What the CEO said is unimportant... what is important, is that each individual note has 90 days to be paid off before it is convertible at a '60% of lowest market price over the past 15 days' rate. The notes are issued in relatively small amounts (i.e., approx 150K), so the financing is favorable as the company "should" be able to pay these back on schedule. Further, if they were to miss one, it wouldn't be a conversion of the entire 1.6M, but rather just that individual 150K missed payment amount.
-Lord
I've accumulated 750K shares throughout the course of today... and let me tell you - I've never seen a shareholder base this strong at levels above the 50 day moving average.
It took me FOREVER to get those buy orders filled at the bargain prices I was aiming for.
I was already excited for the future on account of the impending JV's, but now I'm even more excited, seeing as how strong most the hands are in this stock right now.
Good Luck to ALL
-Lord
So, was that heavy enough volume for you to sell?
Not very heavy in my opinion. Just a technical bounce, as I expected.
Like I stated in my other post, most the buyers in late Nov and early Dec are still well in the green at the 50 day moving average and we saw little to no selling as it approached those levels.
I was only able to load up about 75% of my desired position.
Future is bright here, hope you didn't sell yet Apostle. Those JV's should be fun.
Good Luck to ALL
-Lord
False, that was just NITE masking my buy orders.
The exact amounts were of my purchases so far today.
Someone care to sell me 500K more here?
Agreed, called this one yesterday...
Bounce off the 50 day moving average.
Big Time Green either later today or tomorrow.
Well... it's not good for me! :)
I want more shares...
Got about half my position loaded in the 0.022 - 0.023 range.
Trying to scrape more here but shares are hard to get at this level.
Stalemate here between the .0241 bid and 0.026 ask
Well I won't fault you for that, but you shouldn't cloud your trading based on management with the illusion that it is technically founded.
Hartman should have communicated better though - absolutely agree - but he has also done a hell of a job in terms of non-short-term corporate strategy. Landing an LOI for offshore revenues while eliminating toxic financing arrangements has positioned the company for greatness should the LOI turn into a finalized JV arrangement. This could allow the company to navigate the convoluted process of FDA approval without further dilution.
We'll see....
At this point, it essentially comes down to whether that JV in South America finalizes. IF that goes through, it will be seen as a masterful play by the CEO. IF not, the company is likely finished or returning to the grasps of toxic debt.
-Lord
Thanks, and if it doesn't, I'm happy for you as well. I'll wait for entry at a later point.
You do skew the number though, as you're not taking into account trading volume when you state that SP range of .044 - .022. The volume during the third week of Nov through the second week of December, which occurred primarily at price points nowhere near .044, has yet to sell off. In fact, the majority will still be holding for a profit at .022 (hence the upward trending 50 day moving average).
You may sell... but most won't, unless they are planning on changing their previous behavior.
Best of Luck to All
-Lord
I respect your views, as I've followed your posts throughout most of this, but I'm surprised to see you doubting the technical aspects here. Hell of a stock if this bounces off an RSI at 50 to spike upwards twice within the same 30 days. Definitely bodes well for the long term belief in the company if that happens.
Hope the best for everyone currently holding, I'll be looking to re-enter around $0.022 - $0.024 if the opportunity presents itself. Don't think it'll get much lower than that.
-Lord
Take a step back a bit further, think it'll bounce off the 50 day instead. Likely to see low 2's before it heads back up.
JMHO
Best of Luck to All
-Lord
Something here seems off...
Can someone explain why the buyout was announced in October 2015, for the amount of $7M cash and $7M in CGIX shares.... yet this is currently trading at a market cap of 235K?
There has to be something wrong...
-Lord
Looking good, technicals lining up just like they did before the last run to $14, but with a more favorable RSI this time. Indication of a more sustainable run coming.
Redemption time for AVXL, just in time for the holidays.
Thoughts are always welcome, let me know what ya'll think!
2nd year out of school, still getting this whole thing down.
-Lord
Couldn't agree more Volcano, my thoughts exactly.
Regardless of the current SP fluctuations, the small market is undeniable. $2-3M for a company w/ an imminent 25M joint-venture, promising pre-clinical breast cancer treatment data, and impending revenue from South American sales of Feldetrex is a JOKE.
Best of Luck to ALL.
-Lord
Imminent $25M investment in BIEI and the market cap is appox. $1.5M...
People.... people... c'mon now... one of the easiest investments you'll ever make here.
Best of Luck to All.
-Lord
Able to expound a bit more on this deal?
I'm having a hard time nailing it down precisely.
So SPHS had PRIOR (as in the past) dilution but has still not exercised the portion requiring Aspire to purchase 15M of shares on the open market?
The VWAP provision is almost too good to be true for longs... we could require them to purchase 30% of the outstanding shares on the next trading day; on any given day?
I have to be misunderstanding... b/c that sounds way too good to be true.
Re-post from meh76_1999 on YMB; Scientific Validation of P300 Amp
New Publication Supports Anavex/Neuronetrix P300 Amplitude Data as "Sensitive and Reliable Measure" in Alzheimer's
Anavex associate Neuronetrix has a new featured article (lead author Cecchi) just out in a high-visibility journal sponsored by the Alzheimer's Association, called Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. To find the abstract just search keywords Neuronetrix sciencedirect. Not sure if everyone will be able to read the whole article, but I have access so just in case I'll summarize the key data (for our purposes) below. This particular journal is a new spin-off of a very high-impact journal that many scientists read and cite, so it will catch a lot of important eyes.
The upshot for Anavex is that in a trial of 103 mild AD subjects (MMSE 21-26) and 101 healthy control, Neuronetrix's integrated hardware/software system for data acquisition and automated data analysis methods, which is the system used to gather EEG/ERP data in the ongoing Anavex 2a trial, showed statistically significant correlation between lower P300 amplitude (among many other ERP measures) and mild Alzheimer's. In Table 3, where healthy control registered a voltage of 7.36 +/- 0.39, subjects with mild AD registered a voltage of 5.74 +/- 0.38. That yields a p-value of 0.01, qualifying it as very statistically significant (since there's only a one percent chance the data is accidental).
On slide 23 of the current Anavex corporate presentation, the company cites for comparison to its own data the healthy control data (7.36 +/- 0.39) from the Neuronetrix study, which makes particular sense given that the Anavex P300 data was gathered using the same system. Note that the baseline voltage on slide 23 is just under 5, which makes sense given that the Neuronetrix voltage of 5.74 +/- 0.38 is for mild AD whereas baseline in the Anavex study is for mild-to-moderate AD.
Thus the measurement of 6.7 mV for patients on day 36 of 2-73 gains added weight from how substantially it exceeds the 5.74 +/- 0.38 mild-AD baseline established for the 103 patients in the Neuronetrix study.
Overseas trials are done for multiple reasons.
Most of the smart companies (typically with C levels with 15+ years of medical experience) are moving towards this strategy. Take a look at ADXS and NWBO.
To simplify it: it's easier; less regulation, lower costs, easier for patients to sign up, more institutional space available.
If positive results are achieved, it is extremely difficult for the FDA to reject an advancement to phase III just on the grounds of "you didn't conduct it here." However, this response has been acceptable for full FDA approval, so I would assume (should we advance) that the phase III would be conducted in the US.
Agreed. If we stay green today, it signals the downtrend breaking early. Shouldn't have broken till .35-.38 from what I'm seeing; based on the past trend line. Definitely a big indication that we may be breaking out of the upward triangle this next week.